ONCOLOGY

Overscreening particularly high for women living in metropolitan areas.

Screening outside the recommended age range may cause more harm than good.

Identifies a molecular subtype tied to the greatest benefit with adjuvant chemoradiotherapy.

Prespecified subgroup analyses of SOLO1 trial.

Recommends screening initiation at 25 years in asymptomatic individuals.

Data from the BRCA pathogenic variant carriers' database at the Manchester Centre for Genomic Medicine

Shows potential clinical activity in bevacizumab-naive patients in phase 2 trial.

Hybrid model shows high sensitivity.

Oncologic outcomes are similar to those with an open approach.

No increased complications in this comparison of enhanced recovery, conventional management.

Diagnosis, treatment, funding are all greatly affected.

Recommendation outlines indications, best practices in the postoperative and definitive settings.

Laparoscopic procedure is tied to improved survival in advanced disease.

European Society of Gynaecological Oncology and European Society for Paediatric Oncology joint guidelines.